BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10583025)

  • 21. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
    Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
    Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grapefruit juice-drug interactions.
    Bailey DG; Malcolm J; Arnold O; Spence JD
    Br J Clin Pharmacol; 1998 Aug; 46(2):101-10. PubMed ID: 9723817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of P-glycoprotein on the transport and metabolism of indinavir in Caco-2 cells expressing cytochrome P-450 3A4.
    Hochman JH; Chiba M; Nishime J; Yamazaki M; Lin JH
    J Pharmacol Exp Ther; 2000 Jan; 292(1):310-8. PubMed ID: 10604964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4.
    Achira M; Suzuki H; Ito K; Sugiyama Y
    AAPS PharmSci; 1999; 1(4):E18. PubMed ID: 11741214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
    Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
    J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
    Luo S; Wang Z; Patel M; Khurana V; Zhu X; Pal D; Mitra AK
    Int J Pharm; 2011 Jul; 414(1-2):77-85. PubMed ID: 21571053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition selectivity of grapefruit juice components on human cytochromes P450.
    Tassaneeyakul W; Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Arch Biochem Biophys; 2000 Jun; 378(2):356-63. PubMed ID: 10860553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells.
    Gan LS; Moseley MA; Khosla B; Augustijns PF; Bradshaw TP; Hendren RW; Thakker DR
    Drug Metab Dispos; 1996 Mar; 24(3):344-9. PubMed ID: 8820426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
    Kakar SM; Paine MF; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Grapefruit-felodipine interaction: effect of unprocessed fruit and probable active ingredients.
    Bailey DG; Dresser GK; Kreeft JH; Munoz C; Freeman DJ; Bend JR
    Clin Pharmacol Ther; 2000 Nov; 68(5):468-77. PubMed ID: 11103749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.
    Fuhr U
    Drug Saf; 1998 Apr; 18(4):251-72. PubMed ID: 9565737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism-based inactivation of human cytochrome P450 3A4 by grapefruit juice and red wine.
    Chan WK; Nguyen LT; Miller VP; Harris RZ
    Life Sci; 1998; 62(10):PL135-42. PubMed ID: 9496718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates.
    Tian R; Koyabu N; Takanaga H; Matsuo H; Ohtani H; Sawada Y
    Pharm Res; 2002 Jun; 19(6):802-9. PubMed ID: 12134950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
    Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T
    Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of human cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp) in Caco-2 cell monolayers by selected commercial-source milk thistle and goldenseal products.
    Budzinski JW; Trudeau VL; Drouin CE; Panahi M; Arnason JT; Foster BC
    Can J Physiol Pharmacol; 2007 Sep; 85(9):966-78. PubMed ID: 18066144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Chen G; Weemhoff JL; Jen C; Kelley CJ; LeDuc BW; Zinny MA
    Clin Pharmacol Ther; 2003 Aug; 74(2):121-9. PubMed ID: 12891222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
    Cummins CL; Jacobsen W; Benet LZ
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1036-45. PubMed ID: 11861813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grapefruit juice activates P-glycoprotein-mediated drug transport.
    Soldner A; Christians U; Susanto M; Wacher VJ; Silverman JA; Benet LZ
    Pharm Res; 1999 Apr; 16(4):478-85. PubMed ID: 10227700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.